Recurrent Breast Cancer Terminated Phase 1 / 2 Trials for Cisplatin (DB00515)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01918306GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast CancerTreatment